Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer.

Dreyfuss AD, Barsky AR, Taunk NK, Clark AS, Freedman GM.

Breast J. 2019 Jun 28. doi: 10.1111/tbj.13421. [Epub ahead of print]

PMID:
31254304
2.

Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?

Pomponio MK, Keele LJ, Fox KR, Clark AS, Matro JM, Shulman LN, Tchou JC.

Breast Cancer Res Treat. 2019 Aug;177(1):137-143. doi: 10.1007/s10549-019-05282-0. Epub 2019 May 22.

PMID:
31119565
3.

Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy.

Demissei BG, Finkelman BS, Hubbard RA, Zhang L, Smith AM, Sheline K, McDonald C, Narayan HK, Narayan V, Waxman AJ, Domchek SM, DeMichele A, Shah P, Clark AS, Bradbury AR, Carver JR, Upshaw J, Armenian SH, Liu P, Ky B.

Cancer. 2019 Aug 15;125(16):2762-2771. doi: 10.1002/cncr.32149. Epub 2019 May 1.

PMID:
31042319
4.

PET oestrogen receptor imaging: ready for the clinic?

Mankoff DA, Clark AS.

Lancet Oncol. 2019 Apr;20(4):467-469. doi: 10.1016/S1470-2045(19)30038-5. Epub 2019 Mar 4. No abstract available.

PMID:
30846328
5.

Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT.

Elmi A, Makvandi M, Weng CC, Hou C, Clark AS, Mach RH, Mankoff DA.

Clin Cancer Res. 2019 May 15;25(10):3063-3073. doi: 10.1158/1078-0432.CCR-18-2769. Epub 2019 Jan 28.

PMID:
30692100
6.

Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer.

Clark AS, McAndrew NP, Troxel A, Feldman M, Lal P, Rosen M, Burrell J, Redlinger C, Gallagher M, Bradbury AR, Domchek SM, Fox KR, O'Dwyer PJ, DeMichele AM.

Clin Cancer Res. 2019 Apr 1;25(7):2072-2079. doi: 10.1158/1078-0432.CCR-18-0790. Epub 2019 Jan 11.

PMID:
30635336
7.

Partial validation of a TaqMan real-time quantitative PCR assay for the detection of Panulirus argus virus 1.

Clark AS, Behringer DC, Moss Small J, Waltzek TB.

Dis Aquat Organ. 2018 Aug 14;129(3):193-198. doi: 10.3354/dao03242.

PMID:
30154279
8.

Heart rate and thermal responses to power yoga.

Schubert MM, Clark AS, De La Rosa AB, Newcomer SC.

Complement Ther Clin Pract. 2018 Aug;32:195-199. doi: 10.1016/j.ctcp.2018.07.003. Epub 2018 Jul 17.

PMID:
30057050
9.

Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men.

Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, Shabason JE.

JAMA Oncol. 2018 Oct 1;4(10):e181114. doi: 10.1001/jamaoncol.2018.1114. Epub 2018 Oct 11.

10.

Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

Tchou J, Zhao Y, Levine BL, Zhang PJ, Davis MM, Melenhorst JJ, Kulikovskaya I, Brennan AL, Liu X, Lacey SF, Posey AD Jr, Williams AD, So A, Conejo-Garcia JR, Plesa G, Young RM, McGettigan S, Campbell J, Pierce RH, Matro JM, DeMichele AM, Clark AS, Cooper LJ, Schuchter LM, Vonderheide RH, June CH.

Cancer Immunol Res. 2017 Dec;5(12):1152-1161. doi: 10.1158/2326-6066.CIR-17-0189. Epub 2017 Nov 6.

11.

A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.

Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, Ruiz-Esteves KN, Long LM, Cantave D, Wilson TM, Scott LM, Simakova O, Jung MY, Hahn J, Maric I, Metcalfe DD.

J Allergy Clin Immunol. 2018 Jan;141(1):180-188.e3. doi: 10.1016/j.jaci.2017.05.036. Epub 2017 Jun 16.

12.

Immunotherapy for Breast Cancer: What Are We Missing?

Vonderheide RH, Domchek SM, Clark AS.

Clin Cancer Res. 2017 Jun 1;23(11):2640-2646. doi: 10.1158/1078-0432.CCR-16-2569.

13.

Alcohol misuse-a national pandemic: an investigation to identify whether implementing an alcohol brief intervention service would benefit patients attending an oral and maxillofacial (OMFS) department.

Wright AL, Clark AS, Ward G, Moodie F, Taylor GD, Boyd D, Currie WJ, Hislop WS, Halsnad SM.

Public Health. 2017 Apr;145:20-22. doi: 10.1016/j.puhe.2016.12.009. Epub 2017 Jan 18. No abstract available.

PMID:
28359385
14.

Making Molecular Imaging a Clinical Tool for Precision Oncology: A Review.

Mankoff DA, Farwell MD, Clark AS, Pryma DA.

JAMA Oncol. 2017 May 1;3(5):695-701. doi: 10.1001/jamaoncol.2016.5084. Review.

PMID:
28033451
15.

18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.

Liao GJ, Clark AS, Schubert EK, Mankoff DA.

J Nucl Med. 2016 Aug;57(8):1269-75. doi: 10.2967/jnumed.116.175596. Epub 2016 Jun 15. Review.

16.

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.

Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD.

Arthritis Rheumatol. 2016 Oct;68(10):2403-11. doi: 10.1002/art.39738.

17.

Stable, single-photon emitter in a thin organic crystal for application to quantum-photonic devices.

Polisseni C, Major KD, Boissier S, Grandi S, Clark AS, Hinds EA.

Opt Express. 2016 Mar 7;24(5):5615-5627. doi: 10.1364/OE.24.005615.

18.

Clinical Diagnosis and Management of Breast Cancer.

McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM.

J Nucl Med. 2016 Feb;57 Suppl 1:9S-16S. doi: 10.2967/jnumed.115.157834. Review.

19.

Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.

Fowler AM, Clark AS, Katzenellenbogen JA, Linden HM, Dehdashti F.

J Nucl Med. 2016 Feb;57 Suppl 1:75S-80S. doi: 10.2967/jnumed.115.157933. Review.

20.

HER2 imaging in the ZEPHIR study.

Clark AS, DeMichele A, Mankoff D.

Ann Oncol. 2016 Apr;27(4):555-7. doi: 10.1093/annonc/mdw033. Epub 2016 Jan 22. No abstract available.

PMID:
26802154
21.

Palbociclib (PD0332991)-a Selective and Potent Cyclin-Dependent Kinase Inhibitor: A Review of Pharmacodynamics and Clinical Development.

Clark AS, Karasic TB, DeMichele A, Vaughn DJ, O'Hara M, Perini R, Zhang P, Lal P, Feldman M, Gallagher M, O'Dwyer PJ.

JAMA Oncol. 2016 Feb;2(2):253-60. doi: 10.1001/jamaoncol.2015.4701. Review.

PMID:
26633733
22.

Growth of optical-quality anthracene crystals doped with dibenzoterrylene for controlled single photon production.

Major KD, Lien YH, Polisseni C, Grandi S, Kho KW, Clark AS, Hwang J, Hinds EA.

Rev Sci Instrum. 2015 Aug;86(8):083106. doi: 10.1063/1.4928500.

23.

Bi-photon spectral correlation measurements from a silicon nanowire in the quantum and classical regimes.

Jizan I, Helt LG, Xiong C, Collins MJ, Choi DY, Joon Chae C, Liscidini M, Steel MJ, Eggleton BJ, Clark AS.

Sci Rep. 2015 Jul 28;5:12557. doi: 10.1038/srep12557.

24.

How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.

Farwell MD, Clark AS, Mankoff DA.

JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667. No abstract available.

PMID:
26181243
25.

How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy.

Mankoff DA, Farwell MD, Clark AS, Pryma DA.

Cancer J. 2015 May-Jun;21(3):218-24. doi: 10.1097/PPO.0000000000000116. Review.

PMID:
26049702
26.

Enhancing the heralded single-photon rate from a silicon nanowire by time and wavelength division multiplexing pump pulses.

Zhang X, Jizan I, He J, Clark AS, Choi DY, Chae CJ, Eggleton BJ, Xiong C.

Opt Lett. 2015 Jun 1;40(11):2489-92. doi: 10.1364/OL.40.002489.

PMID:
26030539
27.

Racial disparities in colon cancer survival: a matched cohort study.

Silber JH, Rosenbaum PR, Ross RN, Niknam BA, Ludwig JM, Wang W, Clark AS, Fox KR, Wang M, Even-Shoshan O, Giantonio BJ.

Ann Intern Med. 2014 Dec 16;161(12):845-54. doi: 10.7326/M14-0900.

PMID:
25506853
28.

CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.

DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, Lal P, Feldman M, Zhang P, Colameco C, Lewis D, Langer M, Goodman N, Domchek S, Gogineni K, Rosen M, Fox K, O'Dwyer P.

Clin Cancer Res. 2015 Mar 1;21(5):995-1001. doi: 10.1158/1078-0432.CCR-14-2258. Epub 2014 Dec 11.

29.

Abnormal bone marrow histopathology in paediatric mastocytosis.

Carter MC, Metcalfe DD, Clark AS, Wayne AS, Maric I.

Br J Haematol. 2015 Mar;168(6):865-73. doi: 10.1111/bjh.13231. Epub 2014 Nov 28.

PMID:
25429914
30.

Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.

Clark AS, McDonald E, Lynch MC, Mankoff D.

Oncology (Williston Park). 2014 May;28(5):424-30. Review.

31.

Degenerate photon-pair generation in an ultracompact silicon photonic crystal waveguide.

He J, Clark AS, Collins MJ, Li J, Krauss TF, Eggleton BJ, Xiong C.

Opt Lett. 2014 Jun 15;39(12):3575-8. doi: 10.1364/OL.39.003575.

PMID:
24978540
32.

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657).

Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, DeMichele A; I-SPY1 Investigators.

Cancer Med. 2014 Jun;3(3):693-701. doi: 10.1002/cam4.235. Epub 2014 Apr 9.

33.

Molecular imaging biomarkers for oncology clinical trials.

Mankoff DA, Pryma DA, Clark AS.

J Nucl Med. 2014 Apr;55(4):525-8. doi: 10.2967/jnumed.113.126128. Epub 2014 Mar 10. Review.

34.

Chalcogenide fiber-based distributed temperature sensor with sub-centimeter spatial resolution and enhanced accuracy.

Vo TD, He J, Magi E, Collins MJ, Clark AS, Ferguson BG, Xiong C, Eggleton BJ.

Opt Express. 2014 Jan 27;22(2):1560-8. doi: 10.1364/OE.22.001560.

PMID:
24515162
35.

Mode multiplexed single-photon and classical channels in a few-mode fiber.

Carpenter J, Xiong C, Collins MJ, Li J, Krauss TF, Eggleton BJ, Clark AS, Schröder J.

Opt Express. 2013 Nov 18;21(23):28794-800. doi: 10.1364/OE.21.028794.

PMID:
24514391
36.

Photon pair generation in a silicon micro-ring resonator with reverse bias enhancement.

Engin E, Bonneau D, Natarajan CM, Clark AS, Tanner MG, Hadfield RH, Dorenbos SN, Zwiller V, Ohira K, Suzuki N, Yoshida H, Iizuka N, Ezaki M, O'Brien JL, Thompson MG.

Opt Express. 2013 Nov 18;21(23):27826-34. doi: 10.1364/OE.21.027826.

PMID:
24514299
37.

Bidirectional multiplexing of heralded single photons from a silicon chip.

Xiong C, Vo TD, Collins MJ, Li J, Krauss TF, Steel MJ, Clark AS, Eggleton BJ.

Opt Lett. 2013 Dec 1;38(23):5176-9. doi: 10.1364/OL.38.005176.

PMID:
24281539
38.

Multi-photon absorption limits to heralded single photon sources.

Husko CA, Clark AS, Collins MJ, De Rossi A, Combrié S, Lehoucq G, Rey IH, Krauss TF, Xiong C, Eggleton BJ.

Sci Rep. 2013 Nov 4;3:3087. doi: 10.1038/srep03087.

39.

Integrated spatial multiplexing of heralded single-photon sources.

Collins MJ, Xiong C, Rey IH, Vo TD, He J, Shahnia S, Reardon C, Krauss TF, Steel MJ, Clark AS, Eggleton BJ.

Nat Commun. 2013;4:2582. doi: 10.1038/ncomms3582.

40.

Multicolor quantum metrology with entangled photons.

Bell B, Kannan S, McMillan A, Clark AS, Wadsworth WJ, Rarity JG.

Phys Rev Lett. 2013 Aug 30;111(9):093603. Epub 2013 Aug 29.

PMID:
24033035
41.

Characteristics associated with differences in survival among black and white women with breast cancer.

Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, Wang M, Niknam BA, Ludwig JM, Wang W, Even-Shoshan O, Fox KR.

JAMA. 2013 Jul 24;310(4):389-97. doi: 10.1001/jama.2013.8272.

PMID:
23917289
42.

Two-photon interference between disparate sources for quantum networking.

McMillan AR, Labonté L, Clark AS, Bell B, Alibart O, Martin A, Wadsworth WJ, Tanzilli S, Rarity JG.

Sci Rep. 2013;3:2032. doi: 10.1038/srep02032.

43.

High-efficiency frequency conversion in the single-photon regime.

Clark AS, Shahnia S, Collins MJ, Xiong C, Eggleton BJ.

Opt Lett. 2013 Mar 15;38(6):947-9. doi: 10.1364/OL.38.000947.

PMID:
23503269
44.

Heralded single-photon source in a III-V photonic crystal.

Clark AS, Husko C, Collins MJ, Lehoucq G, Xavier S, De Rossi A, Combrié S, Xiong C, Eggleton BJ.

Opt Lett. 2013 Mar 1;38(5):649-51. doi: 10.1364/OL.38.000649.

PMID:
23455253
45.

Low Raman-noise correlated photon-pair generation in a dispersion-engineered chalcogenide As2S3 planar waveguide.

Collins MJ, Clark AS, He J, Choi DY, Williams RJ, Judge AC, Madden SJ, Withford MJ, Steel MJ, Luther-Davies B, Xiong C, Eggleton BJ.

Opt Lett. 2012 Aug 15;37(16):3393-5. doi: 10.1364/OL.37.003393.

PMID:
23381268
46.

Estrous cycle variations in GABA(A) receptor phosphorylation enable rapid modulation by anabolic androgenic steroids in the medial preoptic area.

Oberlander JG, Porter DM, Onakomaiya MM, Penatti CA, Vithlani M, Moss SJ, Clark AS, Henderson LP.

Neuroscience. 2012 Dec 13;226:397-410. doi: 10.1016/j.neuroscience.2012.09.014. Epub 2012 Sep 16.

47.

The role of the androgen receptor in anabolic androgenic steroid-induced aggressive behavior in C57BL/6J and Tfm mice.

Robinson S, Penatti CA, Clark AS.

Horm Behav. 2012 Jan;61(1):67-75. doi: 10.1016/j.yhbeh.2011.10.004. Epub 2011 Nov 3.

PMID:
22057031
48.

An intact medial preoptic area is necessary for zaprinast to modulate paced mating behavior in female rats.

Meerts SH, Guarraci FA, Clark AS.

Physiol Behav. 2012 Jan 18;105(2):264-8. doi: 10.1016/j.physbeh.2011.08.026. Epub 2011 Aug 28.

PMID:
21893074
49.

Slow-light enhanced correlated photon pair generation in a silicon photonic crystal waveguide.

Xiong C, Monat C, Clark AS, Grillet C, Marshall GD, Steel MJ, Li J, O'Faolain L, Krauss TF, Rarity JG, Eggleton BJ.

Opt Lett. 2011 Sep 1;36(17):3413-5. doi: 10.1364/OL.36.003413.

PMID:
21886228
50.

The display of paced mating behavior in a rat model of endometriosis.

Clark AS, Robinson S, Boisvert E, Quill KA.

Physiol Behav. 2011 Oct 24;104(5):722-7. doi: 10.1016/j.physbeh.2011.07.022. Epub 2011 Jul 27.

PMID:
21820456

Supplemental Content

Loading ...
Support Center